Friday April 3, 2020

Childhood Ignorance and Abuse Leads to Smoking Cigarettes

Childhood physical abuse leads to heavy cigarette use and smoking of other drugs

0
//
Smoking childhood
Children who have been abused, mistreated or neglected at home are more likely to start smoking cigarettes and other substances. Pixabay

Health and lifestyle researchers have found that children who have been abused, mistreated or neglected at home are more likely to start smoking cigarettes and other substances.

The study, published in the journal Substance Use & Misuse, showed that physical abuse of children in high-risk homes, especially when they’re toddlers or teens, dramatically increases the odds that their adolescent experimentation with cigarettes will lead to a heavy smoking habit.

For the findings, the study examined data on children who were at high risk for abuse and neglect — either because they had been referred to a child protective service or lived in conditions associated with the likelihood of maltreatment or both.

Smoking childhood
Adolescent cigarette smoking is a really serious social problem and public health concern. Pixabay

“I wanted to look at different types of maltreatment and whether they have an impact on cigarette smoking,” said study lead author Susan Yoon, Assistant Professor at Ohio State University in the US.

“Adolescent cigarette smoking is a really serious social problem and public health concern. Brain development is not complete until late adolescence or during young adulthood, and cigarette smoking is associated with damage in brain development,” Yoon said.

“We also know that those who start smoking cigarettes during adolescence are more likely to continue smoking into adulthood,” Yoon added.

For the results, the research team used data on 903 adolescents, who were assessed at age 12, 16 and 18.

A breakdown of different types of abuse and neglect experienced by the sample population during three different time periods (early childhood, school age and adolescence) confirmed how vulnerable these kids were.

The researchers used their responses about smoking between the ages of 12 and 18 to identify three patterns of cigarette use: stable low/no use (61 per cent of respondents), gradually increasing use (30 per cent) and sharply increasing cigarette use (nine per cent).

“It was almost shocking how the pattern of cigarette use over time went up so drastically in the sharply increasing use class,” Yoon said.

Smoking
Physical abuse during adolescence had an even stronger effect — this type of mistreatment at that point in life was linked to 3.7 times higher odds for sharply increased cigarette use. Pixabay

“They were pretty similar to the others at age 12 — almost 80 percent didn’t smoke. At age 16, we saw that almost 60 per cent had used cigarettes more than 20 days in the past year and by 18, every single kid in this group reported heavy use of cigarettes,” Yoon added.

A statistical analysis showed that adolescents who experienced early childhood physical abuse were 2.3 times more likely to be in the sharply increasing cigarette use group compared with the stable no/low group.

Physical abuse during adolescence had an even stronger effect — this type of mistreatment at that point in life was linked to 3.7 times higher odds for sharply increased cigarette use.

Also Read- Here’s Why Consumption of Half Pint of Beer a Day May Help You Live Longer

Adolescents who had been neglected during early childhood were 1.89 times more likely to be in the gradually increasing cigarette use group than in the stable no/low use group.

About 40 per cent of these smokers had reported using cigarettes at age 16, and by age 18, more than 80 per cent were smokers, and about 40 per cent had smoked on more than 20 days in the previous year, the study said. (IANS)

Next Story

Shortage of Anti-Malarial Drugs Due to Usage in COVID-19 Treatment

Doctors Warn of Malaria Drug Scarcity

0
Malaria COVID-19
Limited global stocks of two anti-malarial drugs could wreck plans to use the medicines, currently in clinical trials, to treat COVID-19. Pixabay

Limited global stocks of two anti-malarial drugs could wreck plans to use the medicines, currently in clinical trials, to treat COVID-19, doctors cautioned on Thursday. This is the latest health news.

Around the world, countries are expanding access to chloroquine (CQ) and hydroxychloroquine (HCQ), which are used to treat malaria and are known to have anti-viral properties.

The medicines have shown early promise against the COVID-19 illness in studies in France and China.

Please follow NewsGram on Instagram to get updates on the latest news

CQ, which is the less toxic of the two, is also used as an anti-inflammatory to treat conditions like rheumatoid arthritis and lupus, purposes it is primarily known for outside the tropics.

Writing in the Annals of Rheumatic Diseases, doctors in Italy — the country hardest hit by COVID-19 — said that limited supply could scupper any widespread attempt to use the two drugs against the virus.

Malaria COVID-19
Researchers at the Microbiology Research Facility work with coronavirus samples as a trial begins to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. VOA

“In some European countries the availability of HCQ and CQ in the pharmacies (outside the hospitals) is already scarce,” Francesca Romana Spinelli, assistant professor at the Sapienza University of Rome and letter author, told AFP.

“This is an emerging problem for many patients already treated with CQ/HCQ for their autoimmune rheumatic disease.”

Both medicines are known to have anti-viral properties and have shown some encouraging results in trials against COVID-19.

Please follow NewsGram on Facebook to get updates on the latest news

But they have a number of potentially serious side effects, and there are fears that treating COVID-19 patients, many of whom are on medication for underlying conditions, could court disaster.

On Wednesday the European Medicine Agency warned that CQ and HCQ should only be used on COVID-19 patients in clinical trials or in case of a “national emergency”.

 

Also Read- Virus of Hatred and Insanity Wreaking Havoc With the Preventive Measures in India

In the letter, Italian doctors said using CQ and HCQ as widespread COVID-19 treatments would raise ethical concerns, given their known side effects.

“If mass prophylaxis was accepted as an option worldwide, this would raise the question of whether there is enough supply of chloroquine and hydroxychloroquine to support this approach,” they added. (VOA)